A ferroptosis assay is any laboratory test designed to detect whether cells are dying through ferroptosis, a form of cell death driven by the iron-dependent buildup of oxidized fats in cell membranes. Unlike apoptosis (the familiar “programmed cell death” you may have heard about), ferroptosis has its own distinct chemistry, and no single test can confirm it on its own. Researchers typically run a panel of assays, each targeting a different piece of the puzzle, and look for a convergent pattern before declaring that ferroptosis is what killed the cells.
The Three Hallmarks That Define the Target
To understand what a ferroptosis assay is measuring, you need to know what makes ferroptosis ferroptosis. Three essential hallmarks define it: the loss of an enzyme called GPX4 that normally repairs damaged fats in cell membranes, the presence of loose iron that can drive chemical reactions, and the runaway oxidation of specific fat-containing molecules in the membrane called polyunsaturated fatty acid phospholipids.1PubMed Central. The Hallmarks of Ferroptosis Every ferroptosis assay is ultimately probing one or more of these three features. Some measure the damaged fats directly. Some track the iron. Others look at GPX4 activity or the cell’s supply of antioxidant defenses. The most convincing experiments combine several approaches.
The Rescue Test
Before diving into the molecular measurements, it helps to understand the single most common way researchers confirm ferroptosis in a dish. The logic is simple: if you can block the cell death by adding a known ferroptosis inhibitor, and only a ferroptosis inhibitor stops it, you have strong evidence that ferroptosis is the mechanism at work.
Two inhibitors are workhorses in this approach. Ferrostatin-1 is a fat-soluble antioxidant that specifically traps the lipid radicals responsible for ferroptotic damage. Deferoxamine is an iron chelator that binds up the loose iron cells need to drive the oxidation chain. In a well-designed experiment, treating cells with a ferroptosis inducer like erastin or RSL3 should kill them, and then adding ferrostatin-1 or deferoxamine should rescue them, keeping cells alive and suppressing death markers.2STAR Protocols. Protocol to distinguish ferroptosis from other cell death mechanisms in cultured cells This rescue pattern has been confirmed across different cell types. Breast cancer cells highly sensitive to ferroptosis inducers, for example, were rescued by ferrostatin-1, liproxstatin-1 (a related antioxidant), and deferoxamine.3bioRxiv. Assessment of ferroptosis inducers and Nrf2 inhibitors as radiosensitisers in 2D and 3D breast cancer cell cultures
An electrophysiological biosensing platform recently demonstrated the same principle in heart muscle cells: it captured dose- and time-dependent changes during erastin-induced ferroptosis and then recorded the rescue when ferrostatin-1 was added.4PubMed. Quantitative Assessment of Ferroptosis in Cardiomyocytes Using Robust and Reliable Electrophysiological Biosensing The rescue test is not a single assay in the molecular sense, but it is the conceptual backbone of ferroptosis research. Almost every paper claiming ferroptosis will include it.
Measuring Lipid Peroxidation With Fluorescent Probes
The most widely used molecular assay for ferroptosis relies on a fluorescent dye called C11-BODIPY 581/591. This probe sits inside cell membranes and changes color when nearby fats get oxidized: it shifts from red fluorescence to green. Researchers can then read that shift using a flow cytometer (which measures fluorescence in thousands of individual cells) or a fluorescence microscope (which produces images showing where in the cell the oxidation is happening).5PubMed. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591) The dye is lipophilic, meaning it slips easily into membranes, and once oxidized it stays put rather than floating away, which makes the signal reliable for localizing damage.
C11-BODIPY has several practical advantages that explain its popularity. It works at low concentrations, so it does not significantly disturb the membrane it is measuring. It is stable under imaging lights and is not thrown off by changes in pH or solvent conditions. And it responds to the same types of reactive oxygen species that attack real membrane fats, while ignoring some less relevant ones like superoxide and nitric oxide on their own.6PubMed. C11-BODIPY(581/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology
Biochemical Readouts for Lipid Damage
Fluorescent probes are not the only way to measure lipid peroxidation. Researchers also quantify breakdown products of oxidized fats, the most common being malondialdehyde (MDA). When polyunsaturated fats in membranes break down, MDA is one of the small molecules left behind. A simple colorimetric reaction (the TBARS assay) can measure MDA levels in cell lysates or tissue samples, providing a complementary readout.7PubMed Central. The application of approaches in detecting ferroptosis Another breakdown product, 4-hydroxynonenal (4-HNE), is also frequently measured, though 4-HNE accumulation has been linked to other forms of cell death too, including apoptosis and necrosis, so it is less specific to ferroptosis on its own.8Cell Death & Disease. Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure
A Known Limitation of C11-BODIPY
For all its strengths, C11-BODIPY has a documented weakness that researchers should account for. Mass spectrometric analysis has shown that the dye is more sensitive to oxidation than the actual membrane fats it is supposed to report on. This means it can overestimate the extent of lipid damage. Even more problematically, the dye itself acts as a mild antioxidant, which can suppress the very oxidation it is trying to detect. The upshot is that C11-BODIPY fluorescence is a sensitive indicator that oxidative processes are happening, but it does not yield strictly quantitative information about how much lipid damage has occurred.9PubMed. Mass spectrometric analysis demonstrates that BODIPY 581/591 C11 overestimates and inhibits oxidative lipid damage This is why experienced labs pair C11-BODIPY results with at least one other method.
Mass Spectrometry for Molecular Fingerprinting
When researchers need to go beyond “how much” lipid peroxidation occurred and want to know exactly which phospholipid species were oxidized, they turn to liquid chromatography–mass spectrometry (LC-MS). This technique can identify and quantify dozens of oxidized phospholipid species in a single run, providing a molecular fingerprint of the cell’s lipid damage.10PubMed. LC-MS-Based Redox Phosphoipidomics Analysis in Ferroptosis
This level of detail turns out to matter. When researchers compared the oxidized phospholipid profiles of cells dying by ferroptosis, apoptosis, necroptosis, and pyroptosis, they found that ferroptotic cells had a magnitude higher level of oxidized phospholipids overall. The qualitative pattern was also distinct: ferroptotic cells showed mainly oxidized phosphatidylethanolamine, followed by oxidized phosphatidylserine and phosphatidylinositol, while other forms of cell death involved different phospholipid classes.11Cell Death & Disease. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis In other words, mass spectrometry-based lipidomics can distinguish ferroptosis from look-alike forms of cell death that also involve some lipid oxidation. The tradeoff is that it requires expensive equipment, specialized sample preparation, and considerable expertise to interpret.
Tracking the Iron
Because ferroptosis depends on redox-active iron, assays that measure the cell’s labile (loosely bound, reactive) iron pool are another piece of the puzzle. Several fluorescent probes have been developed for this purpose. One widely used tool is FerroOrange (also called RhoNox-4), which shows greater than 100-fold fluorescence enhancement when it encounters labile iron(II). It is sensitive enough for high-throughput screening applications and has been used alongside organelle-targeted probes that revealed labile iron accumulation specifically in lysosomes and the endoplasmic reticulum during ferroptosis.12PubMed Central. N-oxide-based and trioxolane-based fluorescent probes for monitoring labile iron and labile heme: an update Iron measurements alone cannot confirm ferroptosis (iron is involved in many processes), but rising labile iron in conjunction with lipid peroxidation and GPX4 impairment is a strong signal.
Measuring GPX4 Activity and Glutathione Levels
GPX4 is the enzyme that normally prevents the lipid peroxide buildup that drives ferroptosis. When GPX4 is inhibited or degraded, ferroptosis becomes much more likely. Assays for GPX4 can work at the protein level (Western blots to see how much GPX4 protein is present), the activity level (enzymatic assays that measure how well GPX4 reduces lipid peroxides), or the gene expression level (qPCR to measure mRNA). One study used biotin-linked drug pulldown and mass spectrometry to confirm that a compound directly bound GPX4 and inhibited its enzymatic activity.13PubMed Central. Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis
Closely related is measuring the cell’s glutathione supply. Glutathione (GSH) is the molecule GPX4 uses as fuel to do its repair work. When GSH is depleted, GPX4 cannot function, and ferroptosis follows. Researchers track the ratio of oxidized glutathione (GSSG) to reduced glutathione (GSH), and a spike in this ratio flags oxidative stress. In ferroptosis triggered by glutathione depletion specifically, both GSH and GSSG levels drop dramatically, a pattern that differs from oxidative stress where GSSG rises while total glutathione stays relatively stable.14PubMed Central. Protein S-glutathionylation confers cellular resistance to ferroptosis induced by glutathione depletion
What Ferroptotic Cells Look Like Under a Microscope
Transmission electron microscopy (TEM) gives researchers a direct visual readout of ferroptosis. The signature is striking and quite different from apoptosis. Ferroptotic cells do not show the nuclear fragmentation and membrane blebbing of apoptosis. Instead, the mitochondria shrink, their outer membranes become denser, and the internal folds called cristae rupture or disappear entirely.15PubMed. Iron Overload-Dependent Ferroptosis Aggravates LPS-Induced Acute Lung Injury by Impairing Mitochondrial Function Studies have shown that when ferroptosis is experimentally enhanced (for instance, by knocking down the protein frataxin), the mitochondrial damage becomes even more dramatic, with enhanced fragmentation and vanished cristae visible alongside increased free iron and lipid peroxidation.16PubMed Central. Identification of Frataxin as a regulator of ferroptosis
TEM is not a screening tool; preparing samples and imaging them takes time and expertise. But it provides morphological evidence that complements the biochemical assays and is often included in papers as a visual confirmation.
High-Throughput Screening
Drug discovery has pushed the development of ferroptosis assays that can process thousands of compounds quickly. One approach uses iron(II) levels as a screening index: a library of herbal small-molecule compounds was screened in cardiomyocytes, and researchers identified praeruptorin A as a compound capable of lowering iron(II) concentration and inhibiting ferroptosis in a mouse model of heart damage caused by doxorubicin, a common chemotherapy drug.17PubMed. Praeruptorin A screened by a ferrous ion probe inhibited DMT1 and ferroptosis to attenuate Doxorubicin-induced cardiomyopathy
Another strategy targets GPX4 directly using a fluorescence polarization assay. This technique measures whether a small molecule binds to GPX4 protein in a test tube, allowing rapid scanning of compound libraries. Using this method, researchers identified metamizole sodium as a potential GPX4 inhibitor from an in-house compound library.18PubMed. Discovery of GPX4 inhibitors through FP-based high-throughput screening These high-throughput approaches are increasingly important because finding drugs that can either trigger ferroptosis in cancer cells or block it in healthy tissue is a major goal of the field.
Moving Into Living Animals
Cell culture assays are the starting point, but ferroptosis also needs to be detected in living tissue. The methods shift accordingly. In mouse models, researchers commonly stain tissue sections for 4-hydroxynonenal (the lipid peroxidation product) and use TUNEL staining to mark dying cells, sometimes combining these with pharmacological rescue experiments using liproxstatin-1, an inhibitor related to ferrostatin-1.19PubMed Central. In Vivo Assessment of Ferroptosis and Ferroptotic Stress in Mice
Newer tools are pushing toward real-time detection in live animals. A near-infrared fluorescent probe called TT-4, designed to light up when it encounters the viscosity changes caused by lipid peroxidation, was tested in mouse models of liver injury and fatty liver disease. It detected ferroptosis in liver tissue at earlier time points than the standard C11-BODIPY probe, suggesting higher sensitivity for early-stage damage.20PubMed Central. Novel near-infrared probe for monitoring lipid peroxidation-mediated viscosity change in ferroptotic hepatocytes Near-infrared probes are particularly useful for in vivo work because their longer wavelengths penetrate tissue better than the visible-light wavelengths that C11-BODIPY relies on.
Next-Generation Probes That Track Specific Organelles
The latest generation of ferroptosis probes is designed not just to detect oxidative damage in general but to localize it within specific compartments of the cell. One probe (Cy-S4) targets mitochondria and detects hydrogen polysulfide, a signaling molecule whose levels shift during ferroptosis. It responds in about eight seconds with a detection limit of 0.23 micromolar, and has been used to image ferroptosis in cells modeling arthritis-related inflammation.21PubMed Central. A near-infrared ratio fluorescent probe achieves mitochondrial hydrogen polysulfide imaging for monitoring ferroptosis in arthritis
Another probe, called MINU, exploits the fact that mitochondrial membrane potential collapses during ferroptosis. In healthy cells, MINU accumulates in mitochondria; as ferroptosis proceeds and the membrane potential drops, it migrates to the nucleus. By tracking where the fluorescence signal sits, researchers can distinguish ferroptotic cells from apoptotic ones (where the migration pattern differs) and from healthy cells.22PubMed. Monitoring Ferroptosis with NIR Fluorescence Probe Capable of Reversible Mitochondria Nucleus Translocation A dual-channel probe called HCy-OH-mito takes this a step further by simultaneously monitoring a reactive nitrogen species in mitochondria and viscosity changes in lysosomes, providing two independent readouts of ferroptosis from one molecule.23Dyes and Pigments. “Three-key-and-lock” near-infrared fluorescent probe for dual-channel tracking ONOO− in mitochondria and viscosity in lysosomes in ferroptosis and drug-induced liver injury
Noninvasive Imaging in Whole Animals
Perhaps the most ambitious frontier for ferroptosis assays is detecting it inside a living tumor without cutting anything out. Two imaging modalities are being developed for this. MRI-based monitoring has been demonstrated using iron oxide nanoparticles that serve as both ferroptosis-inducing therapy and imaging contrast agents. In prostate cancer mouse models, the T2 value on MRI decreased at tumor sites after treatment and correlated linearly with changes in ferroptosis markers, tumor weight, and volume, effectively allowing researchers to track how well a ferroptosis-based therapy was working in real time.24PubMed Central. MRI-Based Quantitative Evaluation of Tumor Ferroptosis Mediated by A Novel Self-Reducing Nano-Prodrug
PET imaging offers another route. A radiotracer called [18F]hGTS13 targets system xc⁻, the amino acid transporter that supplies cells with cystine (the raw material for making glutathione). In rats bearing brain tumors, this tracer showed high and sustained uptake in the tumor, and uptake dropped when the animals were pre-treated with a ferroptosis inducer that blocks system xc⁻.25PubMed Central. Monitoring of cancer ferroptosis with [18F]hGTS13, a system xc- specific radiotracer Both MRI and PET approaches are still in preclinical stages, but they point toward a future where ferroptosis could be monitored noninvasively in patients receiving cancer therapy.
Why No Single Assay Is Enough
A recurring theme across the field is that every individual ferroptosis assay has blind spots. C11-BODIPY can overestimate damage. MDA and 4-HNE levels rise in other forms of cell death too. Iron accumulation happens in non-ferroptotic contexts. GPX4 levels can change for reasons unrelated to ferroptosis. And mitochondrial morphology, while distinctive, requires expert interpretation. This is why the standard of evidence in the field is convergence: a cell population dying by ferroptosis should show lipid peroxidation (by probe or mass spectrometry), sensitivity to iron chelation, rescue by lipophilic antioxidants, and ideally the characteristic shrunken mitochondria on electron microscopy.26Frontiers in Cell and Developmental Biology. Characteristics and Biomarkers of Ferroptosis
The picture gets more complicated when you consider that ferroptosis can proceed through pathways that do not involve GPX4 at all. Ferroptosis suppressor protein 1 (FSP1) operates independently of the GPX4 system and can suppress ferroptosis on its own by reducing ubiquinone to ubiquinol in cell membranes.27PubMed Central. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance This means an assay focused only on GPX4 and glutathione could miss ferroptotic resistance driven by FSP1, or misinterpret a cell’s vulnerability. Comprehensive assay panels increasingly include FSP1 expression alongside the traditional markers.
For anyone designing or interpreting ferroptosis experiments, the practical lesson is straightforward: plan to measure at least two independent hallmarks, always include the pharmacological rescue controls, and remain skeptical of any single readout that claims to prove ferroptosis in isolation.